Study Shows Human Cytomegalovirus Exploits Tolerogenic Cells
Researchers found tolerogenic dendritic cells offer a permissive niche for the virus that is the leading infectious cause of developmental disabilities in children.
Updated on Nov. 16, 2026 in Allergies

Researchers at TWINCORE reported that tolerogenic dendritic cells are a permissive niche for human cytomegalovirus (HCMV). The findings were published in the European Journal of Immunology.
Why it matters
HCMV is the leading infectious cause of developmental disabilities in children, so understanding how it evades the immune system could inform future prevention and treatment research. The work suggests immune cells that normally dampen responses may instead help the virus persist.
The study compared tolerogenic dendritic cells, generated with dexamethasone or vitamin D3, against conventional monocyte-derived dendritic cells after HCMV exposure. Tolerogenic cells were more susceptible to infection and induced markedly less T-cell proliferation, while the human relevance of these cell populations remains unresolved.
The players
TWINCORE
TWINCORE is a German biomedical research institute, a joint venture of the Helmholtz Centre for Infection Research and Hannover Medical School, where the study was conducted.
The details
Researchers generated tolerogenic dendritic cells by treating them with vitamin D3, dexamethasone, or a combination of both. Dexamethasone-treated cells resisted maturation, while vitamin D3-treated cells remained more responsive to activating signals, and both groups were then exposed to HCMV.
Timeline
Study published in the European Journal of Immunology on 2026-11-16.
Health Landscape
HCMV has been studied for roughly 70 years yet remains the leading infectious cause of developmental disabilities in children. This work adds a specific immune-cell pathway to a long record of research on how the virus evades host defenses.
For now, the findings concern laboratory cells rather than treatment, so there are no changes to care or medication access for patients. Readers caring for young children should continue to follow established public-health guidance on preventing CMV exposure.
The takeaway
Immune cells that normally calm inflammation can be turned into hiding places for a virus, which helps explain how HCMV persists. Follow-up research in human tissue will determine whether this mechanism matters clinically.
Further reading
For more on immune responses and related conditions, explore our Allergies section.



